FdaApplication
BLA 761151
Identifiers
- fda_app_no: BLA761151
Properties
| Property | Value |
|---|---|
| applicant_name | UCB, Inc. |
| application_type | BLA |
| approval_date | 2023-10-17 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BIMZELX | BIMEKIZUMAB-BKZX | 160MG/ML | Injection |
| BIMZELX | — | 160MG/ML | Injection |
| BIMZELX | — | 320MG/2ML (160MG/2ML) | Injection |
| BIMZELX | — | 320MG/2ML (160MG/2ML) | Injection |
4 products